Table. The effect of P2Y12 inhibitors on cardiovascular events in smokers and non‑smokers: a meta-analysis 5.
| Drug | 
Cardiovascular events | 
|
|---|---|---|
| Relative risk reduction in smokers | Relative risk reduction in non-smokers | |
| Clopidogrel | 
25% | 
8% | 
| Prasugrel | 
29% | 
18% | 
| Ticagrelor | 17% | 15% |